PAUL SCHIMMEL - 18 May 2021 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
Director
Signature
Nancy Denyes, Attorney-in-Fact
Issuer symbol
LIFE
Transactions as of
18 May 2021
Transactions value $
$199,000
Form type
4
Filing time
20 May 2021, 08:55:02 UTC
Next filing
22 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common Stock Purchase $199,000 +50,000 +79.3% $3.98 113,023 18 May 2021 See Footnote F2, F3
holding LIFE Common Stock 2,890 18 May 2021 Direct
holding LIFE Common Stock 429,143 18 May 2021 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.
F2 Represents weighted average price for the shares. The shares were purchased at prices ranging from $3.95 to $4.00 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F3 These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.